Effect of hyosine butylbromide on catheter-related bladder discomfort

The therapeutic effect of hyosine butylbromide on catheter-related bladder discomfort in the post-anesthesia care unit: prospective, double-blind, placebo controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000380

Enrollment

Registered

2012-03-12

Start date

2012-02-17

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : After operation, patients who complained of CRBD were randomized with the help of a computer generated table of random numbers into two groups. Group C (Control) patients received placebo (0.9%

whereas Group H (hyosine butylbromide ) patients received hyosine butylbromide 20mg.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) adults (19- 70 yr) of male patients who spontaneously complained of CRBD, after operation 2) ASA physical status I and II 3) informed consent of male sex,

Exclusion criteria

Exclusion criteria: 1) Neurogenic bladder 2) overactive bladder (frequency >3 times in the night or >8 times in 24 h) 3) allergic or contraindication to study drug, chronic analgesic abuse 4) disturbance of the central nervous system end stage renal disease (urine output 1.6 mg dl-1), hepatic disease 7)neurosychiatric disease

Design outcomes

Primary

Measure	Time frame
degree of CRBD	—

Secondary

Measure	Time frame
postoperative nausea and vomitting;Rescue antiemetics;Dry mouth;Facial flushing;Blurred vision;rescue analgesic;sedaiton score	—

Countries

Korea, Republic of

Contacts

Public ContactJung-Hee Ryu

Seoul National University Bundang Hospital

jinaryu@hanmail.net+82-31-787-7497

Outcome results